These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. The discovery of non-benzimidazole and brain-penetrant prolylcarboxypeptidase inhibitors. Graham TH; Shen HC; Liu W; Xiong Y; Verras A; Bleasby K; Bhatt UR; Chabin RM; Chen D; Chen Q; Garcia-Calvo M; Geissler WM; He H; Lassman ME; Shen Z; Tong X; Tung EC; Xie D; Xu S; Colletti SL; Tata JR; Hale JJ; Pinto S; Shen DM Bioorg Med Chem Lett; 2012 Jan; 22(1):658-65. PubMed ID: 22079761 [TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of prolylcarboxypeptidase (PrCP) inhibitors to validate PrCP as a potential target for obesity. Zhou C; Garcia-Calvo M; Pinto S; Lombardo M; Feng Z; Bender K; Pryor KD; Bhatt UR; Chabin RM; Geissler WM; Shen Z; Tong X; Zhang Z; Wong KK; Roy RS; Chapman KT; Yang L; Xiong Y J Med Chem; 2010 Oct; 53(19):7251-63. PubMed ID: 20857914 [TBL] [Abstract][Full Text] [Related]
10. Prolylcarboxypeptidase (PrCP) inhibitors and the therapeutic uses thereof: a patent review. Graham TH Expert Opin Ther Pat; 2017 Oct; 27(10):1077-1088. PubMed ID: 28699813 [TBL] [Abstract][Full Text] [Related]
11. Pyrazoles as non-classical bioisosteres in prolylcarboxypeptidase (PrCP) inhibitors. Graham TH; Shu M; Verras A; Chen Q; Garcia-Calvo M; Li X; Lisnock J; Tong X; Tung EC; Wiltsie J; Hale JJ; Pinto S; Shen DM Bioorg Med Chem Lett; 2014 Apr; 24(7):1657-60. PubMed ID: 24636945 [TBL] [Abstract][Full Text] [Related]
12. Discovery and optimization of 2-phenyloxazole derivatives as diacylglycerol acyltransferase-1 inhibitors. Yun W; Ahmad M; Chen Y; Gillespie P; Conde-Knape K; Kazmer S; Li S; Qian Y; Taub R; Wertheimer SJ; Whittard T; Bolin D Bioorg Med Chem Lett; 2011 Dec; 21(23):7205-9. PubMed ID: 22001092 [TBL] [Abstract][Full Text] [Related]
13. Discovery of N-methyl-1-(1-phenylcyclohexyl)ethanamine, a novel triple serotonin, norepinephrine and dopamine reuptake inhibitor. Shao L; Hewitt MC; Wang F; Malcolm SC; Ma J; Campbell JE; Campbell UC; Engel SR; Spicer NA; Hardy LW; Schreiber R; Spear KL; Varney MA Bioorg Med Chem Lett; 2011 Mar; 21(5):1434-7. PubMed ID: 21310612 [TBL] [Abstract][Full Text] [Related]
14. Discovery of S-adenosyl-L-homocysteine hydrolase inhibitors based on non-adenosine analogs. Nakao A; Suzuki H; Ueno H; Iwasaki H; Setsuta T Bioorg Med Chem Lett; 2014 Sep; 24(17):4336-40. PubMed ID: 25022879 [TBL] [Abstract][Full Text] [Related]
15. Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor. Shao L; Hewitt MC; Wang F; Malcolm SC; Ma J; Campbell JE; Campbell UC; Engel SR; Spicer NA; Hardy LW; Schreiber R; Spear KL; Varney MA Bioorg Med Chem Lett; 2011 Mar; 21(5):1438-41. PubMed ID: 21310609 [TBL] [Abstract][Full Text] [Related]
16. Discovery of 7-aminofuro[2,3-c]pyridine inhibitors of TAK1: optimization of kinase selectivity and pharmacokinetics. Hornberger KR; Chen X; Crew AP; Kleinberg A; Ma L; Mulvihill MJ; Wang J; Wilde VL; Albertella M; Bittner M; Cooke A; Kadhim S; Kahler J; Maresca P; May E; Meyn P; Romashko D; Tokar B; Turton R Bioorg Med Chem Lett; 2013 Aug; 23(16):4511-6. PubMed ID: 23856049 [TBL] [Abstract][Full Text] [Related]
17. Discovery and optimization of 7-aminofuro[2,3-c]pyridine inhibitors of TAK1. Hornberger KR; Berger DM; Crew AP; Dong H; Kleinberg A; Li AH; Medeiros MR; Mulvihill MJ; Siu K; Tarrant J; Wang J; Weng F; Wilde VL; Albertella M; Bittner M; Cooke A; Gray MJ; Maresca P; May E; Meyn P; Peick W; Romashko D; Tanowitz M; Tokar B Bioorg Med Chem Lett; 2013 Aug; 23(16):4517-22. PubMed ID: 23850198 [TBL] [Abstract][Full Text] [Related]
18. Discovery of a new class of glucosylceramide synthase inhibitors. Koltun E; Richards S; Chan V; Nachtigall J; Du H; Noson K; Galan A; Aay N; Hanel A; Harrison A; Zhang J; Won KA; Tam D; Qian F; Wang T; Finn P; Ogilvie K; Rosen J; Mohan R; Larson C; Lamb P; Nuss J; Kearney P Bioorg Med Chem Lett; 2011 Nov; 21(22):6773-7. PubMed ID: 21974949 [TBL] [Abstract][Full Text] [Related]
19. Discovery of a macrocyclic o-aminobenzamide Hsp90 inhibitor with heterocyclic tether that shows extended biomarker activity and in vivo efficacy in a mouse xenograft model. Zapf CW; Bloom JD; McBean JL; Dushin RG; Golas JM; Liu H; Lucas J; Boschelli F; Vogan E; Levin JI Bioorg Med Chem Lett; 2011 Jun; 21(12):3627-31. PubMed ID: 21605975 [TBL] [Abstract][Full Text] [Related]
20. Efficacious 11beta-hydroxysteroid dehydrogenase type I inhibitors in the diet-induced obesity mouse model. Wan ZK; Chenail E; Xiang J; Li HQ; Ipek M; Bard J; Svenson K; Mansour TS; Xu X; Tian X; Suri V; Hahm S; Xing Y; Johnson CE; Li X; Qadri A; Panza D; Perreault M; Tobin JF; Saiah E J Med Chem; 2009 Sep; 52(17):5449-61. PubMed ID: 19673466 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]